Optimal timing of systemic therapy in resectable colorectal liver metastases. - Wikidata - awgldk - TriplyDB

Optimal timing of systemic therapy in resectable colorectal liver metastases.

Optimal timing of systemic therapy in resectable colorectal liver metastases.

http://www.wikidata.org/entity/Q37466299

about

The Feasibility and Safety of Surgery in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study.Surgical management of colorectal cancer metastases to the liver: multimodality approach and a single institutional experience.

P2860

Q33785811-E660314B-EDF1-4405-9943-4DE347229DA3 Q34013522-C661B85A-F0F9-4E36-8725-F3B80CD0B326

P2860

Optimal timing of systemic therapy in resectable colorectal liver metastases.

http://www.wikidata.org/entity/Q37466299

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Optimal timing of systemic therapy in resectable colorectal liver metastases.

@en

Optimal timing of systemic therapy in resectable colorectal liver metastases.

@nl

type

label

Optimal timing of systemic therapy in resectable colorectal liver metastases.

@en

Optimal timing of systemic therapy in resectable colorectal liver metastases.

@nl

prefLabel

Optimal timing of systemic therapy in resectable colorectal liver metastases.

@en

Optimal timing of systemic therapy in resectable colorectal liver metastases.

@nl

P1433

Q37466299-4C90A6A6-958F-41D3-AC7D-58B10444C96F

P1476

Q37466299-1E93FB71-71FC-4FAB-8FFA-A40BC7A02A08

P2093

Q37466299-09E34323-BDDF-4298-A1A2-94AA15C52F72

Q37466299-6A4CC7B4-0C5E-4748-99A6-774D54FCDBB1

Q37466299-6F656239-EC53-4271-B748-67D121459B4F

Q37466299-76D048A7-0789-4B45-8230-C6D432258E4E

Q37466299-80AFD315-89F7-44E0-8A41-023025027C05

Q37466299-9B1D77A4-B8C5-41A2-9E43-D466AE256782

Q37466299-B8A24DC0-94BA-47EF-965B-EECA31FD7287

Q37466299-E6A32E15-F2A1-46F3-BA92-1E6308886AC4

Q37466299-FDF6E888-5C91-4CC8-994E-EF76AAE55981

P2860

Q37466299-1283EF98-DC46-495A-91B1-8AE1FB726828

Q37466299-23F0A80F-E3C9-4165-A7B0-C4FBD68259CE

Q37466299-260116C7-993B-4FE7-B3C8-FBA325C0F353

Q37466299-299B07C7-DEEF-4ADA-AC25-4139105ED36D

Q37466299-2E0D4E4C-0DEC-45A7-BF0A-2794CF0BC948

Q37466299-36F2B2F0-41C9-4EA5-987E-ACE2F08BB265

Q37466299-3C969D19-EC5D-4A13-8C60-DB013D979019

Q37466299-4DC5F501-6B1D-4F4B-80DB-8687593A37BF

Q37466299-5BA5092D-7CB5-4607-933B-384AF59DBA3F

Q37466299-6E4261C1-6C2D-42C8-A475-A15A7E3BD474

P304

Q37466299-13D78B5A-231D-4A95-96D0-FD37221FD9A5

P31

Q37466299-864FF3C6-1E52-43B9-B242-B70B8FBA9AE3

P433

Q37466299-0171CE1B-B1BE-47D6-B4B5-541487A04F3E

P478

Q37466299-26EF7D1A-E43B-439F-98E5-C5363F4D0C90

P577

Q37466299-6220D3D0-EF58-4B6F-A8B3-E3C199838FF2

P698

Q37466299-32CBAD2A-F974-41F9-B47B-25B1A8094FE5

P932

Q37466299-769658EC-AA0F-47C2-AF8C-2CE8292B3FE2

P1433

American Surgeon

P1476

Optimal timing of systemic therapy in resectable colorectal liver metastases.

@en

P2093

Britt Bolemon

http://www.w3.org/2001/XMLSchema#string

Chukwuemeka Ihemelandu

http://www.w3.org/2001/XMLSchema#string

Edward A Levine

http://www.w3.org/2001/XMLSchema#string

George Yacoub

http://www.w3.org/2001/XMLSchema#string

Greg Russell

http://www.w3.org/2001/XMLSchema#string

Matthew Graham

http://www.w3.org/2001/XMLSchema#string

Mebea Aklilu

http://www.w3.org/2001/XMLSchema#string

Perry Shen

http://www.w3.org/2001/XMLSchema#string

Russell Howerton

http://www.w3.org/2001/XMLSchema#string

P2860

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents.

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases.

Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials.

Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome.

Trends in long-term survival following liver resection for hepatic colorectal metastases.

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Solitary colorectal liver metastasis: resection determines outcome.

P304

414-421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23574853

http://www.w3.org/2001/XMLSchema#string

P932

3888812

http://www.w3.org/2001/XMLSchema#string